Gut microbiota interact with breast cancer therapeutics to modulate efficacy.
- 2025-01-16
- Review
- EMBO molecular medicine 17(2)
- Alana A Arnone
- Katherine Ansley
- Arielle L Heeke
- Marissa Howard-McNatt
- Katherine L Cook
- PubMed: 39820166
- DOI: 10.1038/s44321-024-00185-0
- Low evidence
The microbiota's role in modifying the pharmacokinetics of chemotherapy and endocrine-targeting therapies can alter drug efficacy and toxicity profiles... its impact is increasingly recognized.
- Effect
- Beneficial
- Effect size
- Small